IPP Bureau

Touchlight & NEB launch game-changing benchtop DNA kit
Touchlight & NEB launch game-changing benchtop DNA kit

By IPP Bureau - March 20, 2026

This linear, covalently closed, double-stranded DNA offers a rapid, cell-free alternative to traditional plasmid DNA, addressing a critical bottleneck in nucleic acid therapeutics development

MedRabbits launches integrated clinic to revolutionize patient care
MedRabbits launches integrated clinic to revolutionize patient care

By IPP Bureau - March 20, 2026

Rhythm Pharmaceuticals’ Phase 3 EMANATE trial falls short of primary goals
Rhythm Pharmaceuticals’ Phase 3 EMANATE trial falls short of primary goals

By IPP Bureau - March 20, 2026

The study included four independent genetic substudies targeting obesity caused by heterozygous variants in the POMC/PCSK1, LEPR, SRC1 (NCOA1), and SH2B1 genes

Viva Biotech supercharges AI-driven drug discovery with NVIDIA tech
Viva Biotech supercharges AI-driven drug discovery with NVIDIA tech

By IPP Bureau - March 20, 2026

The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology

Roche breaks lab barriers as FDA clears mass spec tests for wider use
Roche breaks lab barriers as FDA clears mass spec tests for wider use

By IPP Bureau - March 20, 2026

The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio

SK bioscience bags fresh backing to accelerate fight against respiratory disease
SK bioscience bags fresh backing to accelerate fight against respiratory disease

By IPP Bureau - March 20, 2026

RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute

NIPER Raebareli–Roche tie-up signals big push for India’s pharma innovation future
NIPER Raebareli–Roche tie-up signals big push for India’s pharma innovation future

By IPP Bureau - March 20, 2026

The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice

Pfizer reports breakthrough in advanced prostate cancer with TALZENNA Plus XTANDI
Pfizer reports breakthrough in advanced prostate cancer with TALZENNA Plus XTANDI

By IPP Bureau - March 20, 2026

The study hit its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) compared to placebo plus XTANDI

Zydus launches Aerolife Mini to simplify inhaler use for asthma and COPD patients
Zydus launches Aerolife Mini to simplify inhaler use for asthma and COPD patients

By IPP Bureau - March 20, 2026

India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease

Glenmark Therapeutics USA launches fluticasone propionate nasal spray
Glenmark Therapeutics USA launches fluticasone propionate nasal spray

By IPP Bureau - March 20, 2026

The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million

Pfizer drug candidate shows strong results in tough breast cancer study
Pfizer drug candidate shows strong results in tough breast cancer study

By IPP Bureau - March 19, 2026

The drug also showed a manageable safety profile, with just 6.4% of patients stopping treatment due to side effects. No new safety concerns emerged

IIT Roorkee unveils cutting-edge molecular medicine facility
IIT Roorkee unveils cutting-edge molecular medicine facility

By IPP Bureau - March 19, 2026

The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics

Roche unveils massive AI factory to supercharge drug development
Roche unveils massive AI factory to supercharge drug development

By IPP Bureau - March 19, 2026

The facility features 2,176 high-performance GPUs across the US and Europe

DrStore partners with TatvaCare to revolutionize diabetes & metabolic care in India
DrStore partners with TatvaCare to revolutionize diabetes & metabolic care in India

By IPP Bureau - March 19, 2026

Alcon walks away from LENSAR deal after regulatory roadblock
Alcon walks away from LENSAR deal after regulatory roadblock

By IPP Bureau - March 19, 2026

At the center of the collapse is opposition from the Federal Trade Commission

Latest Stories

Interviews

Packaging